Versant Capital Management’s Takeda Pharmaceutical TAK Stock Holding History

Versant Capital Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$684K	Buy	42,686 +4,169	+11%	+$69K	0.06%	201
2026 Q1	$713K	Buy	38,517 +3,534	+10%	+$62K	0.07%	188
2025 Q4	$545K	Buy	34,983 +7,913	+29%	+$113K	0.07%	204
2025 Q3	$396K	Buy	27,070 +2,074	+8%	+$30.8K	0.05%	263
2025 Q2	$386K	Sell	24,996 -134	-0.5%	-$1.98K	0.06%	241
2025 Q1	$374K	Buy	25,130 +23,166	+1,180%	+$325K	0.06%	227
2024 Q4	$26K	Buy	+1,964	New	+$27K	0.01%	893
2019 Q2	–	Sell	-10	Closed	–	–	1679
2019 Q1	$0	Buy	+10	New	+$201	﹤0.01%	1725

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Versant Capital Management's TAK Position: Q2 2026 in Review

Versant Capital Management increased its Takeda Pharmaceutical (TAK) stake by 11% in Q2 2026, buying an estimated $69K and bringing the position to 42,686 shares worth $684K. The position accounts for 0.06% of the portfolio, ranked #201.

Versant Capital Management first reported a position in TAK in Q1 2019 and has held it in 8 quarters since. The position peaked at $713K in Q1 2026. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Versant Capital Management held 42,686 shares of Takeda Pharmaceutical worth $684K as of Q2 2026.
Versant Capital Management bought 4,169 Takeda Pharmaceutical shares in Q2 2026, an estimated $69K.
Takeda Pharmaceutical made up 0.06% of Versant Capital Management's portfolio in Q2 2026, its #201 holding.
Versant Capital Management first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 8 quarters since.
Versant Capital Management's Takeda Pharmaceutical position peaked at $713K in Q1 2026.
378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.